Effect of a Single Intravesical Instillation of Mitomycin C on the Intravesical Recurrence Rate After Ureteroscopy for Upper Tract Urothelial Carcinoma: The SINCERE Prospective Multicenter Registry Study

Background: Upper tract urothelial carcinoma (UTUC) is a rare malignancy, accounting for 5–10% of all urothelial carcinomas (UCs). Radical nephroureterectomy (RNU) has been the standard treatment, but kidney-sparing surgery (KSS) via ureteroscopy (URS) is now recommended for low-risk cases. KSS is a...

Full description

Bibliographic Details
Published in:European Urology Open Science
Main Authors: Orlane Figaroa, Ranan Dasgupta, Nora Hendriks, Guido Kamphuis, Jorg Oddens, Jeroen van Moorselaar, Adriaan Bins, Joyce Baard
Format: Article
Language:English
Published: Elsevier 2025-06-01
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666168325001065
_version_ 1849693976087494656
author Orlane Figaroa
Ranan Dasgupta
Nora Hendriks
Guido Kamphuis
Jorg Oddens
Jeroen van Moorselaar
Adriaan Bins
Joyce Baard
author_facet Orlane Figaroa
Ranan Dasgupta
Nora Hendriks
Guido Kamphuis
Jorg Oddens
Jeroen van Moorselaar
Adriaan Bins
Joyce Baard
author_sort Orlane Figaroa
collection DOAJ
container_title European Urology Open Science
description Background: Upper tract urothelial carcinoma (UTUC) is a rare malignancy, accounting for 5–10% of all urothelial carcinomas (UCs). Radical nephroureterectomy (RNU) has been the standard treatment, but kidney-sparing surgery (KSS) via ureteroscopy (URS) is now recommended for low-risk cases. KSS is associated with a higher rate of intravesical recurrence (IVR). The SINCERE study is evaluating whether a single postoperative intravesical instillation of mitomycin C (SI-MMC) after URS can reduce the IVR rate. Study design: This is a prospective multicenter registry study enrolling patients with nonmetastatic UTUC undergoing URS followed by SI-MMC. Data will be compared to a historical control cohort without adjuvant MMC. Patients are aged ≥18 yr with no history of bladder cancer or contralateral UTUC. The study is following the principles of the Declaration of Helsinki and has received ethics approval. Primary and secondary outcomes: The primary outcome is total IVR and time to IVR. The secondary outcome is evaluation of predictive variables for IVR in patients with UTUC after endoscopic treatment. Discussion: Given the high recurrence rate after URS, the study aim is to provide evidence regarding MMC use to reduce IVR and address the current lack of robust data for this strategy. The study has potential to change clinical practice by demonstrating the efficacy of SI-MMC in preventing IVR after URS for UTUC.
format Article
id doaj-art-ce7c7cef13134ecebbc2d0a916bcfcc2
institution Directory of Open Access Journals
issn 2666-1683
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
spelling doaj-art-ce7c7cef13134ecebbc2d0a916bcfcc22025-08-20T02:06:27ZengElsevierEuropean Urology Open Science2666-16832025-06-0176172210.1016/j.euros.2025.03.017Effect of a Single Intravesical Instillation of Mitomycin C on the Intravesical Recurrence Rate After Ureteroscopy for Upper Tract Urothelial Carcinoma: The SINCERE Prospective Multicenter Registry StudyOrlane Figaroa0Ranan Dasgupta1Nora Hendriks2Guido Kamphuis3Jorg Oddens4Jeroen van Moorselaar5Adriaan Bins6Joyce Baard7Department of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands; Corresponding author. Department of Urology, Amsterdam UMC, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. Tel. +31 20 5669111; Fax: +31 20 4446031.Department of Urology, Imperial College Healthcare NHS Trust, London, UKDepartment of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The NetherlandsDepartment of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The NetherlandsDepartment of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The NetherlandsDepartment of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The NetherlandsDepartment of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The NetherlandsDepartment of Urology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands; Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The NetherlandsBackground: Upper tract urothelial carcinoma (UTUC) is a rare malignancy, accounting for 5–10% of all urothelial carcinomas (UCs). Radical nephroureterectomy (RNU) has been the standard treatment, but kidney-sparing surgery (KSS) via ureteroscopy (URS) is now recommended for low-risk cases. KSS is associated with a higher rate of intravesical recurrence (IVR). The SINCERE study is evaluating whether a single postoperative intravesical instillation of mitomycin C (SI-MMC) after URS can reduce the IVR rate. Study design: This is a prospective multicenter registry study enrolling patients with nonmetastatic UTUC undergoing URS followed by SI-MMC. Data will be compared to a historical control cohort without adjuvant MMC. Patients are aged ≥18 yr with no history of bladder cancer or contralateral UTUC. The study is following the principles of the Declaration of Helsinki and has received ethics approval. Primary and secondary outcomes: The primary outcome is total IVR and time to IVR. The secondary outcome is evaluation of predictive variables for IVR in patients with UTUC after endoscopic treatment. Discussion: Given the high recurrence rate after URS, the study aim is to provide evidence regarding MMC use to reduce IVR and address the current lack of robust data for this strategy. The study has potential to change clinical practice by demonstrating the efficacy of SI-MMC in preventing IVR after URS for UTUC.http://www.sciencedirect.com/science/article/pii/S2666168325001065Intravesical recurrenceMitomycin CUpper tract urothelial cancerUreteroscopy
spellingShingle Orlane Figaroa
Ranan Dasgupta
Nora Hendriks
Guido Kamphuis
Jorg Oddens
Jeroen van Moorselaar
Adriaan Bins
Joyce Baard
Effect of a Single Intravesical Instillation of Mitomycin C on the Intravesical Recurrence Rate After Ureteroscopy for Upper Tract Urothelial Carcinoma: The SINCERE Prospective Multicenter Registry Study
Intravesical recurrence
Mitomycin C
Upper tract urothelial cancer
Ureteroscopy
title Effect of a Single Intravesical Instillation of Mitomycin C on the Intravesical Recurrence Rate After Ureteroscopy for Upper Tract Urothelial Carcinoma: The SINCERE Prospective Multicenter Registry Study
title_full Effect of a Single Intravesical Instillation of Mitomycin C on the Intravesical Recurrence Rate After Ureteroscopy for Upper Tract Urothelial Carcinoma: The SINCERE Prospective Multicenter Registry Study
title_fullStr Effect of a Single Intravesical Instillation of Mitomycin C on the Intravesical Recurrence Rate After Ureteroscopy for Upper Tract Urothelial Carcinoma: The SINCERE Prospective Multicenter Registry Study
title_full_unstemmed Effect of a Single Intravesical Instillation of Mitomycin C on the Intravesical Recurrence Rate After Ureteroscopy for Upper Tract Urothelial Carcinoma: The SINCERE Prospective Multicenter Registry Study
title_short Effect of a Single Intravesical Instillation of Mitomycin C on the Intravesical Recurrence Rate After Ureteroscopy for Upper Tract Urothelial Carcinoma: The SINCERE Prospective Multicenter Registry Study
title_sort effect of a single intravesical instillation of mitomycin c on the intravesical recurrence rate after ureteroscopy for upper tract urothelial carcinoma the sincere prospective multicenter registry study
topic Intravesical recurrence
Mitomycin C
Upper tract urothelial cancer
Ureteroscopy
url http://www.sciencedirect.com/science/article/pii/S2666168325001065
work_keys_str_mv AT orlanefigaroa effectofasingleintravesicalinstillationofmitomycincontheintravesicalrecurrencerateafterureteroscopyforuppertracturothelialcarcinomathesincereprospectivemulticenterregistrystudy
AT ranandasgupta effectofasingleintravesicalinstillationofmitomycincontheintravesicalrecurrencerateafterureteroscopyforuppertracturothelialcarcinomathesincereprospectivemulticenterregistrystudy
AT norahendriks effectofasingleintravesicalinstillationofmitomycincontheintravesicalrecurrencerateafterureteroscopyforuppertracturothelialcarcinomathesincereprospectivemulticenterregistrystudy
AT guidokamphuis effectofasingleintravesicalinstillationofmitomycincontheintravesicalrecurrencerateafterureteroscopyforuppertracturothelialcarcinomathesincereprospectivemulticenterregistrystudy
AT jorgoddens effectofasingleintravesicalinstillationofmitomycincontheintravesicalrecurrencerateafterureteroscopyforuppertracturothelialcarcinomathesincereprospectivemulticenterregistrystudy
AT jeroenvanmoorselaar effectofasingleintravesicalinstillationofmitomycincontheintravesicalrecurrencerateafterureteroscopyforuppertracturothelialcarcinomathesincereprospectivemulticenterregistrystudy
AT adriaanbins effectofasingleintravesicalinstillationofmitomycincontheintravesicalrecurrencerateafterureteroscopyforuppertracturothelialcarcinomathesincereprospectivemulticenterregistrystudy
AT joycebaard effectofasingleintravesicalinstillationofmitomycincontheintravesicalrecurrencerateafterureteroscopyforuppertracturothelialcarcinomathesincereprospectivemulticenterregistrystudy